This open-label , multicenter , non-inferiority study enrolled antiretroviral experienced , HIV-infected adults currently receiving a regimen of TDF/FTC + ATV/r for @ months with no history of virologic failure and whose HIV-@ RNA had been @ copies/mL on @ consecutive measurements including screening .